Chlamydia Research
Chlamydia trachomatis (CT) infection is a cause of Pelvic Inflammatory Disease (PID), Ectopic Pregnancy (EP) and infertility, but is usually asymptomatic. The National Chlamydia Screening Programme (NCSP) offers sexually active young men and women annual screening for CT, but its effectiveness and value-for-money have not been definitely established. There has been no consensus on how much reproductive damage untreated CT infection can cause, nor on the best methods for estimating this.
The MPES research group has an on-going programmed of research on Chlamydia.
The first component of this programme was the MRC funded project (G0801947). This was an evidence synthesis approach to the Natural History of Chlamydia trachomatis in women, published in Health Technology Assessment 2016
The second component is part of the University of Bristol’s Health Protection Research Unit, a collaboration between the University and Public Health England. This is investigating the use of serological data to estimate age- and time specific incidence of CT in women in the UK, and in estimate the proportion of Pelvic Inflammatory Disease, salpingitis, ectopic pregnancy, and tubal factor infertility that is caused by CT, the Population Excess Fraction.